Week Against Cancer – A call to bringing forward cancer prevention in Europe

Bladder cancer is Europe’s fifth most common cancer, affecting more than 120,000 people who receive a bladder cancer diagnosis every year across the European Union (EU). The impact of bladder cancer is partly attributed to a lack of awareness regarding its symptoms and risk factors, both among the general population and healthcare professionals. This is compounded by high rates of disease recurrence, unclear treatment, and care pathways, and persistent health disparities. 

All individuals and cancer and health-focused organisations are warmly invited to join to ensure that the implementation of Europe’s Beating Cancer Plan meets the needs identified by the European cancer community and works well for cancer patients, survivors, caregivers, and their families.